|
TRC-D679195-100mg
|
Toronto Research Chemicals
|
2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS] [CAS 666174-80-7]
|
|
|
|
|
TRC-D679195-10mg
|
Toronto Research Chemicals
|
2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS] [CAS 666174-80-7]
|
|
|
|
|
TRC-D679195-50mg
|
Toronto Research Chemicals
|
2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS] [CAS 666174-80-7]
|
|
|
|
|
HY-123023-25ug
|
MedChemexpress LLC
|
12(S)-HETE D8 [CAS 84807-90-9]
|
|
|
|
|
HY-W007856-100mg
|
MedChemexpress LLC
|
5-Methoxysalicylic acid [CAS 2612-02-4]
|
|
|
|
|
HY-W007856-1mL
|
MedChemexpress LLC
|
5-Methoxysalicylic acid [CAS 2612-02-4] (10mM in DMSO)
|
|
|
|
|
HY-140381-100mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-250mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-140381-50mg
|
MedChemexpress LLC
|
Azide-PEG2-Ms [CAS 176520-23-3]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-10mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-100mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-25mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-5mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138363-50mg
|
MedChemexpress LLC
|
Azido-PEG6-MS [CAS 352439-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W096090-1g
|
MedChemexpress LLC
|
Benzyl-PEG4-MS [CAS 477781-69-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W096090-100mg
|
MedChemexpress LLC
|
Benzyl-PEG4-MS [CAS 477781-69-4]
|
|
Cancer-programmed cell death
|
|
|
HY-W096090-500mg
|
MedChemexpress LLC
|
Benzyl-PEG4-MS [CAS 477781-69-4]
|
|
Cancer-programmed cell death
|
|
|
HY-140391-100mg
|
MedChemexpress LLC
|
Boc-NH-PEG4-Ms [CAS 1447797-72-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140391-250mg
|
MedChemexpress LLC
|
Boc-NH-PEG4-Ms [CAS 1447797-72-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140391-50mg
|
MedChemexpress LLC
|
Boc-NH-PEG4-Ms [CAS 1447797-72-9]
|
|
Cancer-programmed cell death
|
|
|
HY-132042-100mg
|
MedChemexpress LLC
|
Bromo-PEG2-MS [CAS 1935075-34-5]
|
|
Cancer-programmed cell death
|
|
|
HY-132042-250mg
|
MedChemexpress LLC
|
Bromo-PEG2-MS [CAS 1935075-34-5]
|
|
Cancer-programmed cell death
|
|
|
HY-132042-50mg
|
MedChemexpress LLC
|
Bromo-PEG2-MS [CAS 1935075-34-5]
|
|
Cancer-programmed cell death
|
|
|
HY-132024-100mg
|
MedChemexpress LLC
|
Bromo-PEG4-MS [CAS 2167807-41-0]
|
|
Cancer-programmed cell death
|
|
|
HY-132024-250mg
|
MedChemexpress LLC
|
Bromo-PEG4-MS [CAS 2167807-41-0]
|
|
Cancer-programmed cell death
|
|
